Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
J Altern Complement Med ; 24(1): 37-47, 2018 Jan.
Article in English | MEDLINE | ID: mdl-29314866

ABSTRACT

OBJECTIVE: The purpose of this study was to investigate the effects of supplementation with a spearmint (Mentha spicata L.) extract, high in polyphenols including rosmarinic acid, on cognitive performance, sleep, and mood in individuals with age-associated memory impairment (AAMI). DESIGN: Subjects with AAMI (N = 90; 67% female; age = 59.4 ± 0.6 years) were randomly assigned (n = 30/group) to consume 900, 600, or 0 mg/day (two capsules, once daily) spearmint extract for 90 days, in this double-blind, placebo-controlled trial. Assessments were completed for cognition (days 0, 45, and 90), sleep (days 0 and 90), and mood (days 0 and 90) by using the Cognitive Drug Research (CDR) System™, Leeds Sleep Evaluation Questionnaire (LSEQ), and Profile of Mood States (POMS™), respectively. RESULTS: Quality of working memory and spatial working memory accuracy improved after supplementation with 900 mg/day spearmint extract by 15% (p = 0.0469) and 9% (p = 0.0456), respectively, versus placebo. Subjects consuming 900 mg/day spearmint extract reported improvement in their ability to fall asleep, relative to subjects consuming placebo (p = 0.0046). Overall treatment effects were evident for vigor-activity (p = 0.0399), total mood disturbance (p = 0.0374), and alertness and behavior following wakefulness (p = 0.0415), with trends observed for improvements after spearmint supplementation relative to placebo. CONCLUSIONS: These results suggest that the distinct spearmint extract may be a beneficial nutritional intervention for cognitive health in older subjects with AAMI.


Subject(s)
Memory Disorders/drug therapy , Memory, Short-Term/drug effects , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Cinnamates , Cognition/drug effects , Depsides , Female , Humans , Male , Mentha spicata , Middle Aged , Polyphenols , Sleep/drug effects , Rosmarinic Acid
2.
Physiol Behav ; 165: 328-38, 2016 10 15.
Article in English | MEDLINE | ID: mdl-27527000

ABSTRACT

Oxidative damage is one of the hallmarks of the aging process. The current study evaluated effects of two proprietary antioxidant-based ingredients, rosemary extract and spearmint extract containing carnosic acid and rosmarinic acid, respectively, on learning and memory in the SAMP8 mouse model of accelerated aging. The two rosemary extracts contained carnosic acid (60% or 10% carnosic acid) and one spearmint extract contained 5% rosmarinic acid. Three doses of actives in each extract were tested: 32, 16, 1.6 or 0mg/kg. After 90days of treatment mice were tested in T-maze foot shock avoidance, object recognition and lever press. Rosemary extract containing 60% carnosic acid improved acquisition and retention in T-maze foot shock, object recognition and lever press. Rosemary extract with 10% carnosic acid improved retention in T-maze foot shock avoidance and lever press. Spearmint with 5% rosmarinic acid improved acquisition and retention in T-maze foot shock avoidance and object recognition. 4-hydroxynonenal (HNE) was reduced in the brain cortex after treatment with all three extracts (P<0.001) compared to the vehicle treated SAMP8. Protein carbonyls were reduced in the hippocampus after administration of rosemary with 10% carnosic acid (P<0.05) and spearmint containing 5% rosmarinic acid (P<0.001). The current results indicate that the extracts from spearmint and rosemary have beneficial effects on learning and memory and brain tissue markers of oxidation that occur with age in SAMP8 mice.


Subject(s)
Abietanes/pharmacology , Cinnamates/pharmacology , Depsides/pharmacology , Maze Learning/drug effects , Recognition, Psychology/drug effects , Rosmarinus/chemistry , Aging/drug effects , Aging/genetics , Aldehydes/metabolism , Analysis of Variance , Animals , Conditioning, Classical/drug effects , Conditioning, Operant/drug effects , Dose-Response Relationship, Drug , Electroshock , Mice , Mice, Mutant Strains , Oxidative Stress/drug effects , Reinforcement, Psychology , Triglycerides/metabolism , Tyrosine/analogs & derivatives , Tyrosine/metabolism , Rosmarinic Acid
3.
Food Nutr Res ; 59: 30034, 2015.
Article in English | MEDLINE | ID: mdl-26689317

ABSTRACT

BACKGROUND: Exercise can initiate a cascade of inflammatory and oxidative stress-related events leading to delayed onset muscle soreness. Polyphenols possess antioxidant and anti-inflammatory properties. OBJECTIVE: The current study examined the effects of a proprietary polyphenolic blend (PB), containing catechins and theaflavins, on exercise performance and recovery following an eccentric exercise challenge. DESIGN: Male participants (18-35 years of age) received placebo or PB at a low dose (PB-L, 1,000 mg/d) or high dose (PB-H, 2,000 mg/d) for 13 weeks. During the 13th week of supplementation, participants completed an eccentric exercise (40 min downhill treadmill run) followed by a strength assessment (peak torque on isokinetic leg extensions) pre-exercise, and 24, 48, and 96 h post-exercise. Muscle soreness (subjective questionnaire), markers of muscle stress (cortisol and creatine phosphokinase [CK]), and antioxidant capacity (ferric reducing ability of plasma [FRAP]) were also assessed. RESULTS: PB-H attenuated the decrease in peak torque observed in the placebo group from pre-exercise to 48 h (p=0.012) and 96 h (p=0.003) post-exercise. At 48 h post-exercise, PB-H reduced whole body and hamstring soreness (p=0.029) versus placebo. Chronic consumption of PB improved serum FRAP (p=0.039). As expected, serum cortisol and CK increased from pre- to post-exercise in all groups; however, by 96 h, cortisol and CK levels returned to pre-exercise levels following PB supplementation. At 96 h, the change in cortisol from pre- to post-exercise was significantly greater in placebo versus PB-H (p=0.039). CONCLUSION: These findings show that chronic consumption of PB improved antioxidant status, reduced markers of muscle stress, and promoted strength recovery post-exercise.

4.
Regul Toxicol Pharmacol ; 71(2): 213-24, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25527048

ABSTRACT

A proprietary dry spearmint extract containing 15.4% rosmarinic acid was assessed in a 90-day study with Sprague-Dawley rats that were gavaged at 0, 422 (low), 844 (mid), or 1948 (high) mg dry spearmint extract/kg bw/day, (equivalent to 0, 65, 130, or 300 mg rosmarinic acid/kg bw/day, respectively). No treatment-related clinical signs or adverse effects were observed in body weight, feed consumption, neurological parameters, hematology, clinical chemistry, gross pathology, and histopathology. However, there were statistically significant increases in the absolute and relative weight of the pituitary gland in mid- and high-dose males, absolute and relative weight of the thyroid gland in the high-dose groups of both sexes and in mid-dose males, and absolute and relative weight of the salivary glands in high-dose females compared to vehicle control group. These changes were considered non-adverse since no corresponding microscopic changes were seen. Based on these findings, the no-observed-adverse-effect level (NOAEL) for the dry spearmint extract was 1948 mg extract/kg bw/day, the highest dose tested, in Sprague-Dawley rats. In addition, the extract showed no mutagenic activity in the Ames assay using Salmonella typhimurium strains (TA98, TA100, TA102, TA1535, and TA1537) and did not induce chromosomal aberrations when tested with human peripheral blood lymphocytes.


Subject(s)
Mentha spicata , Plant Extracts/administration & dosage , Adult , Animals , Cells, Cultured , Female , Humans , Leukocytes, Mononuclear/drug effects , Male , Mentha spicata/adverse effects , Plant Extracts/adverse effects , Rats , Rats, Sprague-Dawley , Toxicity Tests, Acute/methods
5.
Vet Clin North Am Small Anim Pract ; 34(1): 229-47, 2004 Jan.
Article in English | MEDLINE | ID: mdl-15032130

ABSTRACT

Mounting research demonstrates that certain nutraceutical compounds interact with the immune system. These interactions may be positive or negative depending on the compound or dose administered to the individual. Understanding the mechanisms by which these compounds work should provide opportunities to design nutritional interventions to bolster the health of dogs and cats.


Subject(s)
Adjuvants, Immunologic/administration & dosage , Animal Feed , Animal Nutritional Physiological Phenomena , Cats/immunology , Dogs/immunology , Food, Organic , Aging/immunology , Animals , Physical Conditioning, Animal/physiology
6.
J Immunol ; 168(9): 4495-503, 2002 May 01.
Article in English | MEDLINE | ID: mdl-11970994

ABSTRACT

Vitamin A deficiency diminishes Th2-mediated Ab responses, and high-level dietary vitamin A or treatment with the vitamin A metabolite retinoic acid (RA) enhances such responses. To identify a potential mechanism(s) underlying this in vivo activity of vitamin A, we examined the effects of all-trans and 9-cis RA on development of Th1 and Th2 cell populations using in vitro stimulation of Ag-naive Th0 cells from the DO11.10 TCR-transgenic mouse. Treatment with 9-cis, but not with all-trans RA, at primary stimulation strongly enhanced Th2 development. IL-4-neutralizing Ab blocked this activity, but IL-12- and IFN-gamma-neutralizing Ab did not. Because 9-cis RA regulates gene transcription via either RA receptors or retinoid X receptors (RXRs), we tested the Th2-enhancing activities of the RXR- and RA receptor-selective agonists AGN194204 and 4-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid (TTNPB). AGN194204 strongly enhanced Th2 development, whereas TTNPB did not. This RXR agonist also enhanced Th2 development when purified, naive Th0 cells (L-selectin(high)/CD4(+)) were stimulated with CD3 and CD28 Abs in the absence of APCs. During primary antigenic stimulation of naive Th0 cells from DO11.10 mice, AGN194204 increased IL-4 and IL-5 production, decreased IFN-gamma production, increased mRNA in responding T cells for genes involved in Th2 development (IL-4, GATA-3, and c-maf), and decreased mRNA for genes involved in Th1 development (IFN-gamma, T-bet, and IL-12R). These data show that stimulation of the RXR pathway enhances Th2 development, perhaps by affecting the relative expression of pertinent transcription factors, cytokines, and cytokine receptors.


Subject(s)
Receptors, Retinoic Acid/metabolism , Th2 Cells/immunology , Transcription Factors/metabolism , Vitamin A/pharmacology , Alitretinoin , Animals , Cells, Cultured , Cytokines/genetics , Cytokines/physiology , Dose-Response Relationship, Drug , Drug Synergism , Fatty Acids, Unsaturated/pharmacology , Interleukin-12/antagonists & inhibitors , Interleukin-12/physiology , Interleukin-4/pharmacology , Kinetics , Male , Mice , Mice, Inbred BALB C , Mice, Transgenic , RNA, Messenger/biosynthesis , Receptors, Antigen, T-Cell, alpha-beta/genetics , Receptors, Retinoic Acid/agonists , Retinoid X Receptors , Signal Transduction , Tetrahydronaphthalenes/pharmacology , Th1 Cells/drug effects , Th1 Cells/immunology , Th2 Cells/drug effects , Transcription Factors/agonists , Tretinoin/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...